Share Search
Visit the Share Search
E-therapeutics Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-01-2023 | 31-01-2022 | 31-01-2021 | 31-01-2020 | 31-01-2019 |
| Revenue | 0.47 | 0.48 | 0.32 | 0.46 | 0.04 |
| Operating Profit / Loss | -10.24 | -9.57 | -4.49 | -2.89 | -5.11 |
| Net Interest | 0.47 | 0.05 | 0.02 | 0.01 | 0.03 |
| Pre Tax Profit | -9.77 | -9.52 | -4.47 | -2.87 | -5.08 |
| Post Tax Profit | -8.27 | -8.07 | -3.68 | -2.35 | -4.00 |
| Profit for the Period | -8.27 | -8.07 | -3.68 | -2.35 | -4.00 |
| Equity Holders of Parent Company | -8.27 | -8.07 | -3.68 | -2.35 | -4.00 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -1.54p | -1.65p | -0.99p | -0.87p | -1.49p |
| Earnings per Share (Diluted) | -1.54p | -1.65p | -0.99p | -0.87p | -1.49p |
| Earnings per Share (Adjusted) | -1.54p | -1.65p | -0.99p | -0.87p | -1.49p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -1.54p | -1.65p | -0.99p | -0.87p | -1.49p |
| Earnings per Share (Diluted) | -1.54p | -1.65p | -0.99p | -0.87p | -1.49p |
| Earnings per Share (Adjusted) | -1.54p | -1.65p | -0.99p | -0.87p | -1.49p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-01-2023 | 31-01-2022 | 31-01-2021 | 31-01-2020 | 31-01-2019 |
| Non-Current Assets | |||||
| Intangible Assets | 0.24 | 0.10 | 0.08 | 0.11 | 0.12 |
| Property, Plant and Equipment | 0.40 | 0.81 | 0.08 | 0.09 | 0.04 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Assets | 0.64 | 0.91 | 0.16 | 0.20 | 0.16 |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | 2.31 | 2.21 | 1.12 | 0.19 | 1.44 |
| Cash at Bank and in Hand | 31.69 | 11.35 | 7.00 | 3.84 | 5.90 |
| Current Asset Investments | n/a | 15.05 | 6.02 | n/a | n/a |
| Other Current Assets | n/a | n/a | n/a | 0.56 | n/a |
| Total Current Assets | 34.00 | 28.61 | 14.15 | 4.58 | 7.35 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 34.64 | 29.52 | 14.31 | 4.79 | 7.51 |
| Current Liabilities | |||||
| Borrowings | 0.29 | 0.39 | 0.02 | 0.05 | n/a |
| Other Current Liabilities | 1.30 | 1.10 | 0.40 | 0.21 | 0.71 |
| Total Current Liabilities | 1.60 | 1.49 | 0.43 | 0.26 | 0.71 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | n/a | 0.29 | n/a | 0.02 | n/a |
| Provisions | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Liabilities | n/a | 0.29 | n/a | 0.02 | n/a |
| Net Assets | 33.04 | 27.73 | 13.88 | 4.50 | 6.80 |
| Capital and Reserves | |||||
| Share Capital | 0.58 | 0.52 | 0.42 | 0.27 | 0.27 |
| Share Premium Account | 112.61 | 99.24 | 77.67 | 65.18 | 65.17 |
| Other Reserves | n/a | n/a | n/a | n/a | n/a |
| Retained Earnings | -80.15 | -72.03 | -64.20 | -60.94 | -58.63 |
| Shareholders Funds | 33.04 | 27.73 | 13.88 | 4.50 | 6.80 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 33.04 | 27.73 | 13.88 | 4.50 | 6.80 |
| 31-01-2023 | 31-01-2022 | 31-01-2021 | 31-01-2020 | 31-01-2019 | |
| Operating Margin | -2,155.58% | -2,005.66% | -1,414.83% | -628.26% | -11,622.73% |
| Return on Capital Employed | -30.93% | -33.79% | -32.44% | -64.56% | -76.52% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 5.63p | 4.74p | 2.37p | 0.75p | 1.15p |